5 Healthcare Stocks to Buy According to Billionaire Mario Gabelli

In this article, we discuss the 5 healthcare stocks to buy according to Mario Gabelli. If you want to read our detailed analysis of these stocks, go directly to the 10 Healthcare Stocks to Buy According to Billionaire Mario Gabelli.

At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Let’s now take a look at Gabelli’s healthcare stock picks:

5. Zoetis Inc. (NYSE: ZTS)

Number of Hedge Fund Holders: 58     

Zoetis Inc. (NYSE: ZTS) is ranked fifth on our list of 10 healthcare stocks to buy according to Mario Gabelli. The company makes and sells animal medicines and is headquartered in New Jersey. Latest filings reveal that GAMCO Investors owned 105,050 shares in the company at the end of the second quarter of 2021 worth $19 million, representing 0.16% of the portfolio. 

On August 25, investment advisory Argus maintained a Buy rating on Zoetis Inc. (NYSE: ZTS) stock and raised the price target to $225 from $195, noting the upgrade reflected the improved outlook on the firm following solid quarterly results posted earlier. 

Out of the hedge funds being tracked by Insider Monkey, London-based investment firm Marshall Wace LLP is a leading shareholder in Zoetis Inc. (NYSE: ZTS) with 951,285 shares worth more than $177 million.  

In its Q2 2021 investor letter, Polen Capital, an asset management firm, highlighted a few stocks and Zoetis Inc. (NYSE: ZTS)  was one of them. Here is what the fund said:

“As is usually the case, Portfolio turnover was modest during the quarter. We trimmed Zoetis. The Zoetis trim is simply an acknowledgement of the company’s current valuation, which we assess is elevated.”